NFATC2 and breast cancer: Indeed, NFAT1 (NFATc2) exerts a pro-invasive function and is mainly expressed in the triple-negative subtype, whereas NFAT3 (NFATc4) has anti-invasive properties, limiting the aggressiveness of primary NFAT3-expressing luminal breast cancer cells (3–6).